Revolution Medicines

ISIN US76155X1000

 | 

WKN A2PYWG

Market cap (in EUR)
34,286 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Show more Show less
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 34,286 m
EPS, EUR -6.10
P/B ratio 24.6
P/E ratio -
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR -
Net income, EUR -1,003 m
Profit margin -

What ETF is Revolution Medicines in?

There are 22 ETFs which contain Revolution Medicines. All of these ETFs are listed in the table below. The ETF with the largest weighting of Revolution Medicines is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
UBS Core MSCI World UCITS ETF USD acc 0.03%
Equity
World
9,851
iShares MSCI World UCITS ETF (Dist) 0.02%
Equity
World
8,072
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.08%
Equity
World
Health Care
Social/Environmental
539
iShares MSCI ACWI UCITS ETF USD (Acc) 0.02%
Equity
World
29,594
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist 0.01%
Equity
North America
Social/Environmental
Climate Change
40
iShares MSCI USA Screened UCITS ETF USD (Dist) 0.04%
Equity
United States
Social/Environmental
1,425
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.03%
Equity
World
Social/Environmental
586
UBS Core MSCI World UCITS ETF hEUR acc 0.03%
Equity
World
904
UBS Core MSCI USA UCITS ETF EUR Hedged dis 0.04%
Equity
United States
187
Xtrackers MSCI World UCITS ETF 1D 0.03%
Equity
World
4,749
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.41%
Equity
United States
Small Cap
224
iShares MSCI USA CTB Enhanced ESG UCITS ETF USD (Dist) 0.08%
Equity
United States
Social/Environmental
15,007
iShares MSCI World CTB Enhanced ESG UCITS ETF USD (Dist) 0.02%
Equity
World
Social/Environmental
591
iShares MSCI North America UCITS ETF 0.03%
Equity
North America
1,243
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 2.48%
Equity
United States
Health Care
Biotech
62
UBS Core MSCI World UCITS ETF USD dis 0.03%
Equity
World
1,931
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.05%
Equity
North America
Social/Environmental
27
iShares MSCI World Screened UCITS ETF USD (Dist) 0.03%
Equity
World
Social/Environmental
1,059
iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist) 0.01%
Equity
World
Social/Environmental
Climate Change
183
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist) 0.18%
Equity
United States
Momentum
15
UBS Core MSCI World UCITS ETF hGBP dis 0.03%
Equity
World
108
UBS Core MSCI USA UCITS ETF USD dis 0.04%
Equity
United States
1,274
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.